Biomarin Pharmaceutical
(NASDAQ:BMRN)
At close: Jun 24
37.5%
Overview Rating
Speculative
Technicals Analysis
66
0100
Financials Analysis
20
0100

Biomarin Pharmaceutical (NASDAQ:BMRN) Stock Quotes, Forecast and News Summary

Biomarin Pharmaceutical Stock (NASDAQ: BMRN) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.4.127K / 2.517M
Day Range- - -
52 Wk Range73.675 - 99.560
Market Cap$15.914B
P/E Ratio78.981
Dividend Yield-
ExchangeNASDAQ
RSI
57
Short Interest
1.61%
Days to Cover1.18
20%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
1
Jan
2
Feb
3
1
Apr
1
1
May
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.2
Hold
Strong Buy
Buy
Hold
Sell
Strong Sell

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
BMRN
LEGN

FAQ

Q

How do I buy Biomarin Pharmaceutical (BMRN) stock?

A

You can purchase shares of Biomarin Pharmaceutical (NASDAQ:BMRN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Biomarin Pharmaceutical (BMRN) competitors?

Q

What is the target price for Biomarin Pharmaceutical (BMRN) stock?

A

There is no analysis for Biomarin Pharmaceutical

Q

What is the forecast for Biomarin Pharmaceutical (BMRN) stock?

A

Biomarin Pharmaceutical has a consensus price target of $95.50.

Q

Current stock price for Biomarin Pharmaceutical (BMRN)?

A

The stock price for Biomarin Pharmaceutical (NASDAQ: BMRN) is $83.81 last updated Today at June 24, 2024 at 8:29 AM EDT.

Q

Does Biomarin Pharmaceutical (BMRN) pay a dividend

A

There are no upcoming dividends for Biomarin Pharmaceutical.

Q

When is Biomarin Pharmaceutical (NASDAQ:BMRN) reporting earnings?

A

Biomarin Pharmaceutical’s Q2 earnings are confirmed for Monday, July 29, 2024.

Q

Is Biomarin Pharmaceutical (BMRN) going to split?

A

There is no upcoming split for Biomarin Pharmaceutical.

Q

What sector and industry does Biomarin Pharmaceutical (BMRN) operate in?

A

Biomarin Pharmaceutical is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch